Key Takeaways
- HeraMED’s HeraCARE platform successfully completed Phase 1 of its pilot program with Lee Health in the U.S.
- 92% of participating patients preferred virtual prenatal visits, resulting in reduced in-person appointments and enhanced patient engagement.
- Lee Health is set to make a decision on advancing to Phase 2 within the next few weeks.
Successful Pilot Program with Lee Health
HeraMED (ASX: HMD) has marked a significant milestone by completing Phase 1 of its pilot program with Lee Health, a leading healthcare provider in the United States. This six-month pilot aimed to validate the efficacy of the HeraCARE platform within a hybrid obstetrics care model, focusing on the use of virtual visits, remote patient monitoring (RPM), fetal Doppler, and blood pressure monitoring to lessen the need for in-person appointments while still ensuring high-quality care.
The pilot involved 44 patients, with an impressive 92% opting for the digital pathway. Not only did all participants express willingness to recommend the program, but the outcomes also indicated that prenatal care could be effectively delivered with fewer in-person visits while maintaining strong patient engagement and access. The Digital Pregnancy Journey program registered a Net Promoter Score (NPS) of 60. The RPM component was exceptionally well received, achieving an NPS of 75, with over 80% of patients believing that the app and RPM improved their access to vital information.
The pilot’s structure featured 11 virtual prenatal visits compared to the traditional model of approximately 15 in-person appointments. HeraMED asserts that this approach can sustain existing care quality. The pilot demonstrated the capacity to create an additional 32 prenatal appointment slots and reduced necessary travel by around 74 miles per patient. This model showcases the potential for Lee Health to enhance clinic access and operational efficiency, addressing practical barriers many patients face.
Dr. Rachel Wykes from Lee Health observed that minimizing unnecessary office visits while maintaining patient connection could significantly elevate the pregnancy care experience and expand service capacity.
As the largest healthcare network in southwest Florida, Lee Health performs around 8,000 deliveries annually and has been exploring digital-first models as part of its transformation strategy. HeraMED views the pilot as a robust validation of the HeraCARE platform’s ability to facilitate connected maternity care at scale, factoring in clinical, operational, and economic metrics.
HeraMED’s CEO, Anoushka Gungadin, noted the importance of partnering with a nationally recognized U.S. healthcare provider. She expressed enthusiasm about the collaboration’s focus on enhancing patient engagement through the HeraCARE model. This pilot sets the groundwork for further scalability and potential expansion of digital maternity care solutions.
The content above is a summary. For more details, see the source article.